title: Favorable response to composite treatment including infliximab in a case of granulomatous cheilitis with Crohn's disease.
authors: Department of Dermatology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
authors: Monji
authors: M
authors: Koga
authors: Department of Pathology, Fukuoka University Hospital, Fukuoka, Japan.
authors: Kaori
authors: K
authors: Koga
authors: Department of Dermatology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
authors: Ryoko
authors: R
authors: Tatsukawa
authors: Department of Dermatology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
authors: Shinichi
authors: S
authors: Imafuku
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use*; D008297:Male; D008556:Melkersson-Rosenthal Syndrome / Q000150:complications / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D055815:Young Adult
chemical_list: D000305:Adrenal Cortex Hormones; D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab